Immunization, Hib3 in Ecuador
Ecuador: Immunization, Hib3 was 70.0% in 2024. ▼ Falling
Immunization, Hib3 in Ecuador, 2003–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
In 2024, immunization, hib3 in Ecuador stood at 70.0%.
Compared with earlier readings it is down 15.7% over ten years.
Over the whole period, immunization, hib3 in Ecuador peaked at 95.0% in 2007 and was at its lowest, 54.0%, in 2003.
Ecuador ranks 166th of 191 countries on this measure, in the bottom quarter.
The long-run direction has been consistently falling across the 22 years of available data.
Immunization, Hib3 in Ecuador, year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 2003 | 54.0% | — |
| 2004 | 86.0% | +59.3% |
| 2005 | 90.0% | +4.7% |
| 2006 | 94.0% | +4.4% |
| 2007 | 95.0% | +1.1% |
| 2008 | 95.0% | +0.0% |
| 2009 | 93.0% | -2.1% |
| 2010 | 90.0% | -3.2% |
| 2011 | 88.0% | -2.2% |
| 2012 | 87.0% | -1.1% |
| 2013 | 87.0% | +0.0% |
| 2014 | 83.0% | -4.6% |
| 2015 | 78.0% | -6.0% |
| 2016 | 83.0% | +6.4% |
| 2017 | 85.0% | +2.4% |
| 2018 | 85.0% | +0.0% |
| 2019 | 85.0% | +0.0% |
| 2020 | 70.0% | -17.6% |
| 2021 | 68.0% | -2.9% |
| 2022 | 70.0% | +2.9% |
| 2023 | 70.0% | +0.0% |
| 2024 | 70.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 86.7% | 54.0% | 95.0% | 7 |
| 2010s | 85.1% | 78.0% | 90.0% | 10 |
| 2020s | 69.6% | 68.0% | 70.0% | 5 |
Countries ranked near Ecuador
More health data for Ecuador
- Un projection of annual infant deaths, annual growth rate -1.67 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6766 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,324 deaths per 1,000 people (2090)
- Number of infants who die before age 1 354 deaths (2100)
- Population ages 15-19, male, annual growth rate 0.6337 % change on previous year (2025)
- Population ages 15-19, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 15-19, male, per capita 0.0443 units per person (2025)
- Population ages 20-24, female, annual growth rate -0.3573 % change on previous year (2025)
- Population ages 20-24, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 20-24, female, per capita 0.0417 units per person (2025)
Frequently asked questions
- What is immunization, hib3 in Ecuador?
- Immunization, hib3 in Ecuador was 70.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in Ecuador?
- The highest recorded value was 95.0% in 2007.
- What is the lowest immunization, hib3 recorded in Ecuador?
- The lowest recorded value was 54.0% in 2003.
- How does Ecuador rank for immunization, hib3?
- Ecuador ranks 166th out of 191 countries with data for 2024.
- Is immunization, hib3 rising or falling in Ecuador?
- Over the last ten years it is down 15.7%. The long-run trend across the full record is falling.
- Where does this Ecuador data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 22 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.